Download PDF
Klin Monbl Augenheilkd 2005; 222(2): 81-89
DOI: 10.1055/s-2005-857935
Übersicht

© Georg Thieme Verlag KG Stuttgart · New York

Antiinfektive medikamentöse Therapie in der Augenheilkunde - Teil 2: Virale Infektionen

Anti-Infective Drug Therapy in Ophthalmology - Part 2: Viral InfectionsT. Reinhard1 , L. L. Hansen1 , M. Pache1 , W. Behrens-Baumann2
  • 1Augenklinik des Universitätsklinikums, Freiburg
  • 2Augenklinik des Universitätsklinikums, Magdeburg
Further Information

Publication History

Eingegangen: 26.11.2004

Angenommen: 28.12.2004

Publication Date:
17 February 2005 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

In dieser Übersicht werden die ophthalmologischen Krankheitsbilder, die durch Herpes-simplex-Viren, Varicella-zoster-Viren, Epstein-Barr-Viren, Cytomegalieviren und Adenoviren verursacht werden, kurz beschrieben. Die wesentlichen therapeutischen Möglichkeiten werden insbesondere unter Berücksichtigung prospektiv randomisierter Studien beschrieben.

Abstract

In this review ophthalmological diseases caused by herpes simplex virus, varicella zoster virus, Epstein-Barr virus, cytomegaly virus or adenovirus are described briefly. The main therapeutic options are discussed placing emphasis especially on prospective randomised trials.

Schlüsselwörter

Virostatika - Herpes-simplex-Viren - Varicella-zoster-Viren - Epstein-Barr-Viren - Cytomegalieviren - Adenoviren - Keratitis - Uveitis - Retinits

Key words

Antivirals - herpes simplex virus - varicella zoster virus - Epstein-Barr virus - cytomegaly virus - adenovirus - keratitis - uveitis - retinitis

Literatur

  • 1 Ahmed I, Ai E. Medical management of cytomegalovirus retinitis.  Ophthalmol Clin North Am. 1997;  10 15-25
    PubMedGoogle Scholar
  • 2 Akler M E, Johnson D W, Burman W J. et al . Anterior uveitis and hypotony after intravenous cidofovir for the treatment of cytomegalovirus retinitis.  Ophthalmology. 1998;  105 651-657
    CrossrefPubMedGoogle Scholar
  • 3 Ameye C, Sundmacher R, De Clerq E. Topical BVDU plus low-dosage steroids in the treatment of chronic relapsing zoster keratouveitis. A pilot study.  Graefe’s Arch Clin Exp Ophthalmol. 1989;  227 118-122
    PubMedGoogle Scholar
  • 4 Barron B A, Gee L, Hauck W W. et al . Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis.  Ophthalmology. 1994;  101 1871-1882
    PubMedGoogle Scholar
  • 5 Behrens-Baumann W, Weber U, Ansorg R. Aciclovir und bakterielle Hornhautinfektion. Eine tierexperimentelle Studie.  Ber Dtsch Ophthalmol Ges. 1981;  78 399-401
    PubMedGoogle Scholar
  • 6 Behrens-Baumann W. Phosphonoformate (Foscarnet, PFA) versus trifluorthymidine in the treatment of keratitis dendritica in the human. A double-blind, randomized, preliminary trial.  Acta Ophthalmol. 1992;  70 690-692
    PubMedGoogle Scholar
  • 7 Centifanto-Fitzgerald Y M, Fenger T, Kaufman H E. Virus proteins in herpetic keratitis.  Exp Eye Res. 1982;  35 425-441
    CrossrefPubMedGoogle Scholar
  • 8 Centifanto-Fitzgerald Y M, Yamaguchi T, Kaufman H E. et al . Ocular disease pattern induced by herpes simplex virus is genetically determined by specific region of viral DNA.  J Exp Med. 1982;  155 475-489
    CrossrefPubMedGoogle Scholar
  • 9 Chodosh J, Astley R A, Butler M G. et al . Adenovirus keratitis: A role for interleukin-8.  Invest Ophthalmol Vis Sci. 2000;  41 783-789
    PubMedGoogle Scholar
  • 10 Cohen E J, Rapuano C J, Laibson P R. External Diseases. Tasman W, Jaeger EA The Wills Eye Hospital atlas of clinical ophthalmology Philadelphia, USA; Lippincott-Raven Publishers 1996: 17-19
    Google Scholar
  • 11 Colin J, Hoh H B, Easty D L. et al . Ganciclovir ophthalmic gel (Virgan; 0,15 %) in the treatment of herpes simplex keratitis.  Cornea. 1997;  16 393-399
    PubMedGoogle Scholar
  • 12 Collum L M, Logan P, Ravenscroft T. Acyclovir in herpetic disciform keratitis.  Br J Ophthalmol. 1983;  67 115-117
    CrossrefPubMedGoogle Scholar
  • 13 Collum L M, McGettrick P, Akhtar J. et al . Oral acyclovir in herpes simplex dendritic corneal ulceration.  Br J Ophthalmol. 1986;  70 435-438
    PubMedGoogle Scholar
  • 14 Corey L, Whitley R J, Stone E F. et al . Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome.  Lancet. 1988;  January 2 1-4
    PubMedGoogle Scholar
  • 15 Crouse C A, Pflugfelder S C, Pereira I. et al . Detection of herpes viral genomes in normal and diseased corneal epithelium.  Curr Eye Res. 1990;  9 569-581
    PubMedGoogle Scholar
  • 16 Culbertson W W, Blumenkranz M S, Pepose J S. et al . Varicella zoster virus is a cause of the acute retinal necrosis syndrome.  Ophthalmology. 1986;  93 559-569
    PubMedGoogle Scholar
  • 17 Culbertson W W, Atherton S S. Acute retinal necrosis and similar retinitis syndromes.  Ophthalmology. 1993;  33 129-143
    PubMedGoogle Scholar
  • 18 Culbertson W W, Dix R D. Varicella-Zoster Virus diseases: Posterior Segment of the Eye. Pepose JS, Holland GN, Williams KR Ocular Infection and Immunology St Louis, USA; Mosby 1996: 1131-1154
    Google Scholar
  • 19 Dawson C R, Togni B. Herpes simplex eye infections. Clinical manifestation, pathogenesis and management.  Surv Opthalmol. 1976;  21 121-135
    PubMedGoogle Scholar
  • 20 Engstrom R E Jr, Holland G N, Margolis T P. et al . The progressive outer retinal necrosis syndrome: a variant of necrotizing herpetic retinopathy in patients with AIDS.  Ophthalmology. 1994;  101 1488-1502
    PubMedGoogle Scholar
  • 21 Gerling J, Neumann-Haefelin D, Seuffert H M. et al . Diagnosis and management of the acute reinal necrosis syndrome.  Ger J Ophthalmol. 1992;  1 388-393
    PubMedGoogle Scholar
  • 22 Günther R. Pathologisch-anatomischer Befund einer Hornhaut bei Keratitis epidemica.  Klin Monatsbl Augenheilk. 1939;  103 309-314
    PubMedGoogle Scholar
  • 23 Hansen L L. Retinale Erkrankungen bei AIDS.  Ophthalmologe. 1993;  90 239-249
    PubMedGoogle Scholar
  • 24 Hansen L L. HIV-Infektion und Auge.  Ophthalmologe. 2000;  97 718-736
    CrossrefPubMedGoogle Scholar
  • 25 Herpetic Eye Disease Study Group . A controlled trial of topical corticosteroids for herpes simplex stromal keratitis.  Ophthalmology. 1994;  101 1883-1895
    PubMedGoogle Scholar
  • 26 Herpetic Eye Disease Study Group . A controlled trial of oral acyclovir for iridocyclitis caused by herpes simplex virus.  Arch Ophthalmol. 1996;  114 1065-1072
    PubMedGoogle Scholar
  • 27 Herpetic Eye Disease Study Group . Acyclovir for the prevention of recurrent herpes simplex virus eye disease.  N Engl J Med. 1998;  339 340-341
    CrossrefPubMedGoogle Scholar
  • 28 Hillenkamp J, Reinhard T, Ross R S. et al . Topical treatment of acute adenoviral keratoconjunctivitis with 0.2 % Cidofovir and 1 % Cyclosporin A: A controlled clinical pilot study.  Arch Ophthalmol. 2001;  109 845-850
    PubMedGoogle Scholar
  • 29 Hillenkamp J, Reinhard T, Ross R S. et al . The effects of Cidofovir 1 % with and without Cyclosporin A 1 % as a topical treatment of acute adenoviral keratoconjunctivitis. A controlled clinical pilot study.  Ophthalmology. 2002;  109 845-850
    CrossrefPubMedGoogle Scholar
  • 30 Hoh H B, Hurley C, Claoue C. et al . Randomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study.  Br J Ophthalmol. 1996;  80 140-142
    CrossrefPubMedGoogle Scholar
  • 31 Holland E J, Mozayeni R M, Schwartz G S. Herpes simplex keratitis. Krachmer JH, Mannis MJ, Holland EJ Cornea. St Louis, Missouri, USA; Mosby 1997: 1191-1223
    Google Scholar
  • 32 Holland G N. Executive committee of the American uveitis society. Standard diagnostic criteria for the acute retinal necrosis syndrome.  Am J Ophthalmol. 1994;  117: 663-667
    PubMedGoogle Scholar
  • 33 Kaufman H E, Centifanto-Fitzgerald Y M, Varnell E D. Herpes simplex keratitis.  Ophthalmology. 1983;  90 700-706
    PubMedGoogle Scholar
  • 34 Kersten A, Reinhard T, Sundmacher R. Postoperative Komplikationen nach perforierender Keratoplastik in Herpesaugen.  Ophthalmologe. 1997;  94 889-896
    CrossrefPubMedGoogle Scholar
  • 35 Lalezari J P. Cidofovir: a new therapy for cytomegalovirus retinitis.  J Acqu Imm Def Syndr Hum Retrovirol. 1997;  14 (S1) 22-26
    PubMedGoogle Scholar
  • 36 Liesegang T J. Herpes zoster keratitis. Krachmer JH, Mannis MJ, Holland EJ Cornea. St Louis, Missouri, USA; Mosby 1997: 1225-1242
    Google Scholar
  • 37 Lund O E, Stefani F H. Corneal histology after epidemic keratoconjunctivitis.  Arch Ophthalmol. 1978;  96 2085-2088
    PubMedGoogle Scholar
  • 38 Margolis T P, Atherton S S. Herpes simplex virus diseases: posterior segment of the eye. Pepose JS, Holland GN, Williams KR Ocular Infection and Immunology St Louis, USA; Mosby 1996: 1155-1167
    Google Scholar
  • 39 Maugdal P C, De Clerq E, Missotten L. Efficacy of bromovinyldeoxyuridine in the treatment of herpes simplex virus and varicella zoster virus in eye infections.  Antiviral Res. 1984;  4 281-291
    CrossrefPubMedGoogle Scholar
  • 40 Maugdal P C, Dieltiens M, De Clerq E. et al .Topical Bromovinyldeoxyuridine treatment of herpes simplex keratitis. Maugdal PC, Missotten L Herpetic eye diseases Dordrecht; Junk 1985: 247-255
    Google Scholar
  • 41 Mayer K, Reinhard T, Reis A. et al . Synergistic effect of acyclovir and mycophenolate mofetil following keratoplasty in patients with herpetic eye disease.  Graefe’s Arch Clin Exp Ophthalmol. 2003;  241 1051-1054
    CrossrefPubMedGoogle Scholar
  • 42 Nahmias A J, Visintine A M, Caldwell D R. et al . Eye infections with herpes simplex viruses in neonates.  Surv Ophthalmol. 1976;  21 100-105
    PubMedGoogle Scholar
  • 43 Neoh C, Harding S P, Saunders D. et al . Comparison of topical and oral acyclovir in early herpes zoster ophthalmicus.  Eye. 1994;  8 688-691
    CrossrefPubMedGoogle Scholar
  • 44 Palay D A, Sternberg P Jr, Davis J. et al . Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy.  Am J Ophthalmol. 1991;  112 250-255
    CrossrefPubMedGoogle Scholar
  • 45 Reinhard T, Godehadt E, Pfahl H G. et al . Lokales Cyclosporin A bei Nummuli nach Keratoconjunktivitis epidemica. Eine Pilotstudie.  Ophthalmologe. 2000;  97 764-768
    CrossrefPubMedGoogle Scholar
  • 46 Reinhard T, Reis A, Mayweg S. et al . Lokales FK506 bei entzündlichen Erkrankungen von Hornhaut und Bindehaut.  Klin Monatsbl Augenheilk. 2002;  219 125-131
    PubMedGoogle Scholar
  • 47 Reinhard T, Adams O, Sundmacher R. Detection of the Epstein-Barr virus genome in the anterior chamber of a patient with chronic uveitis.  Acta Ophthalmol. 2003;  81 671-673
    PubMedGoogle Scholar
  • 48 Rossa V, Sundmacher R. Lokale Interferonprophylaxe einer „epidemischen” Konjunktivitis durch ein nicht identifizierbares Virus.  Klin Monatsbl Augenheilk. 1991;  199 192-194
    PubMedGoogle Scholar
  • 49 Smeraglia R, Hoachadel J, Varnell E D. et al . The role of herpes simplex virus secreted glycoproteins in herpetic keratitis.  Exp Eye Res. 1982;  35 443-459
    CrossrefPubMedGoogle Scholar
  • 50 Sundmacher R, Neumann-Haefelin D, Cantell D. Interferon treatment of dendritic keratitis.  Lancet. 1976;  I 1406
    PubMedGoogle Scholar
  • 51 Sundmacher R, Cantell K, Haug P. et al . Role of debridement and interferon in the treatment of dendritic keratitis.  Graefe’s Arch Clin Exp Ophthalmol. 1978;  207 77-82
    PubMedGoogle Scholar
  • 52 Sundmacher R, Neumann-Haefelin D, Cantell K. Trials with interferon in ophthalmic zoster. Sundmacher R Herpetische Augenerkrankungen München; Bergmann Verlag 1981: 465-468
    Google Scholar
  • 53 Sundmacher R. A clinico-virologic classification of herpetic anterior segment diseases with special reference to intraocular herpes. Sundmacher R Herpetische Augenerkrankungen München; Bergmann Verlag 1981: 203-210
    Google Scholar
  • 54 Sundmacher R. Orale Acyclovir-Theapie von i. o. Herpes simplex Virus Infektionen.  Klin Monatsbl Augenheilk. 1983;  183 246-250
    PubMedGoogle Scholar
  • 55 Sundmacher R. Therapie der herpetischen Erkrankungen des vorderen Augenabschnitts.  Klin Monatsbl Augenheilk. 1985;  186 421-425
    PubMedGoogle Scholar
  • 56 Sundmacher R, Engelskirchen U. Zum Problem der rezidivierenden und persistierenden Numuli nach Keratoconjunctivitis epidemica.  Klin Monatsbl Augenheilk. 1991;  198 550-554
    PubMedGoogle Scholar
  • 57 Sundmacher R, Hillenkamp J, Reinhard T. Perspektiven von Therapie und Prophylaxe der Adenoviruskeratokonjunktivitis.  Ophthalmologe. 2001;  98 991-1009
    CrossrefPubMedGoogle Scholar
  • 58 Stamler J F. Viral conjunctivitis. Krachmer JH, Mannis MJ, Holland EJ Cornea. St. Louis, Missouri, USA; Mosby 1997: 773-777
    Google Scholar
  • 59 Trauzettel-Klosinski S, Sundmacher R, Wigand R. Die Wirkung von Steroiden bei Keratoconjunctivitis epidemica.  Klin Monatsbl Augenheilk. 1980;  176 899-906
    PubMedGoogle Scholar
  • 60 Tsai C S, Ritch R, Straus S E. et al . Antibodies to Epstein-Barr virus in iridocorneal endothelial syndrome.  Arch Ophthalmol. 1990;  108 1572-1576
    PubMedGoogle Scholar
  • 61 Uruyama A, Yamada N, Sasaki T. et al . Unilateral acute uveitis with retinal periarteritis and detachment.  Jpn Clin Ophthalmol. 1971;  25 607-629
    PubMedGoogle Scholar
  • 62 Wander A H, Centifanto Y M, Kaufman H E. Strain specifity of clinical isolates of herpes simplex virus.  Arch Ophthalmol. 1980;  98 1458-1461
    PubMedGoogle Scholar
  • 63 Wilhelmus K R. Interventions for herpes simplex virus epithelial keratitis.  The Cochrane database of systematic reviews. 2004; 
    PubMedGoogle Scholar
  • 64 Zimmer C, Nieuwenhuis I, Danisevskis M. et al . Plötzliche Erblindung bei einem AIDS-Patienten.  Klin Mbl Augenheilk. 1991;  199 48-52
    PubMedGoogle Scholar

Prof. Dr. T. Reinhard

Augenklinik des Universitätsklinikums

Killianstraße 5

79106 Freiburg

Phone: ++ 49/7 61/2 70-40 06

Fax: ++ 49/7 61/2 70-40 63

Email: Reinhard@aug.ukl.uni-freiburg.de